Delfina Care Raises $17M Series A for AI Maternal Health Expansion

Delfina Care has secured $17 million in Series A funding to enhance its AI-powered maternal health platform, aiming to address the maternal health crisis in the U.S. The funding round was led by U.S. Venture Partners, with participation from notable investors such as Mayo Clinic and ARTIS Ventures. The company's technology combines predictive analytics and tailored interventions to improve maternal and infant health outcomes, particularly for at-risk populations. With reported reductions in preterm births and maternal morbidity, Delfina emphasizes its commitment to equitable care and has guaranteed significant cost savings for health plans. The maternal mortality rate in the U.S. is alarmingly high, particularly among Black women, highlighting the urgent need for innovative solutions like Delfina's. This investment reflects a growing interest in maternal health technologies, as evidenced by several recent funding rounds in the sector.